Kames Capital Management’s Celgene Corp CELG Stock Holding History

Kames Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$60.7M	Buy	542,941 +31,321	+6%	+$3.3M	1.79%	22
2014 Q3	$48.5M	Sell	511,620 -816	-0.2%	-$73.6K	1.51%	22
2014 Q2	$44M	Sell	512,436 -85,774	-14%	-$6.52M	1.4%	26
2014 Q1	$41.8M	Sell	598,210 -40	-0%	-$3.17K	1.32%	30
2013 Q4	$50.5M	Sell	598,250 -76,180	-11%	-$6.03M	1.68%	19
2013 Q3	$51.9M	Sell	674,430 -197,608	-23%	-$13.8M	1.6%	15
2013 Q2	$51M	Buy	+872,038	New	+$52.5M	1.79%	16

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Kames Capital Management's CELG Position: Q4 2014 in Review

Kames Capital Management increased its Celgene Corp (CELG) stake by 6.1% in Q4 2014, buying an estimated $3.3M and bringing the position to 542,941 shares worth $60.7M. The position accounts for 1.79% of the portfolio, ranked #22.

Kames Capital Management first reported a position in CELG in Q2 2013 and has held it in 7 quarters since. 1,161 funds tracked by Wall St. Rank hold CELG as of Q4 2014.

Kames Capital Management held 542,941 shares of Celgene Corp worth $60.7M as of Q4 2014.
Kames Capital Management bought 31,321 Celgene Corp shares in Q4 2014, an estimated $3.3M.
Celgene Corp made up 1.79% of Kames Capital Management's portfolio in Q4 2014, its #22 holding.
Kames Capital Management first reported a position in Celgene Corp in Q2 2013 and has held it in 7 quarters since.
1,161 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2014.

Based on Kames Capital Management's 13F filing for Q4 2014, filed 3 Feb 2015.